marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 09-26-2024
Benitec Biopharma Financial Ratios 2011-2024 | BNTC
Annual Financial Ratios Benitec Biopharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -0.2 | -0.0 | -0.6 | -0.9 | 3.0 | -3.5 | -4.3 | -0.7 | -8.6 | -2.5 | - | - | - |
P/S |
- | 54.5 | 4.8 | 145.6 | 79.0 | 0.8 | 64.9 | 41.9 | 35.1 | 91.6 | 27.0 | - | - | - |
EPS |
-5.5 | -5.7 | -37.9 | -3.2 | -8.1 | 3.0 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
-10.2 M | 5.87 M | -620 K | -9.81 M | -793 K | -4.58 M | 31.4 M | 19.8 M | 12.9 M | 77.2 M | 29 M | 872 K | - | - |
EBITDA per Share |
-5.52 | -13.7 | -36.8 | -3.11 | -7.74 | 3.14 | -12 | -6.83 | -28.3 | -20.6 | -103 | - | - | - |
EV/EBITDA |
0.7 | 0.3 | -2.7 | -2.1 | -1.4 | 0.1 | -7.5 | -0.7 | - | - | - | |||
PEG |
-0.01 | -0.0 | -0.0 | 0.01 | 0.0 | -0.02 | -0.05 | 0.05 | -0.01 | 0.11 | -0.08 | - | - | - |
P/B |
0.8 | 20.2 | 0.1 | 0.4 | 0.7 | 0.5 | 2.1 | 1.1 | 0.9 | 4.1 | 1.2 | - | - | - |
P/CF |
-1.8 | -0.2 | -0.0 | -0.7 | -1.0 | 2.3 | -4.1 | -2.9 | -0.8 | -9.7 | -2.9 | - | - | - |
ROE % |
-46.04 | -9684.16 | -631.78 | -69.38 | -80.82 | 17.30 | -62.10 | -26.46 | -131.54 | -48.20 | -48.20 | - | - | - |
ROA % |
-41.66 | -438.22 | -304.84 | -64.93 | -71.41 | 14.93 | -54.55 | -25.10 | -124.58 | -45.10 | -45.10 | - | - | - |
ROCE % |
-47.60 | -9446.04 | -619.50 | -67.95 | -79.24 | 15.32 | -61.95 | -25.15 | -113.35 | -43.71 | -46.11 | - | - | - |
Current Ratio |
10.5 | 1.0 | 1.9 | 15.6 | 9.5 | 7.1 | 8.2 | 19.7 | 18.7 | 15.3 | 15.3 | - | - | - |
DSO |
- | 141.1 | 70.0 | 259.8 | 222.0 | 81.7 | 2505.0 | 2744.4 | 768.5 | 83.1 | 41.5 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | -556.4 | 1259.2 | 469.4 | 233.5 | 1412.7 | 6935.0 | 6935.0 | - | - | - |
Operating Cycle |
- | 141.1 | 70.0 | 259.8 | 222.0 | 81.7 | 2505.0 | 2744.4 | 768.5 | 83.1 | 41.5 | - | - | - |
Cash Conversion Cycle |
- | 141.1 | 70.0 | 259.8 | 778.4 | -1177.5 | 2035.6 | 2510.9 | -644.2 | -6851.9 | -6893.5 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Benitec Biopharma
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.64 | -2.64 | -2.76 | - | -2.67 | -3.34 | -7.98 | -0.55 | -0.4 | -0.59 | -0.62 | -1.21 | -0.82 | -0.76 | -2.45 | -0.76 | -2.45 | -2 | -1.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.57 | -2.68 | -2.71 | - | -2.62 | -3.43 | -7.11 | -1.24 | -0.42 | -0.58 | -0.58 | -1.17 | -0.78 | -0.74 | -2.39 | -0.73 | -2.39 | -1.97 | -1.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-201.14 | -257.22 | -273.44 | -188.31 | -552.78 | -503.03 | -487.36 | -485.11 | -169.95 | -159.00 | -136.75 | -126.38 | -99.31 | -101.84 | -93.31 | -77.83 | -55.60 | -20.46 | -6.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-135.86 | -160.83 | -174.44 | -127.06 | -302.92 | -281.97 | -270.92 | -271.09 | -141.38 | -132.44 | -119.00 | -127.19 | -109.10 | -108.96 | -88.00 | -51.52 | -23.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-199.22 | -255.32 | -272.92 | -185.82 | -539.40 | -493.30 | -475.55 | -475.36 | -170.05 | -148.55 | -126.22 | -113.45 | -87.47 | -97.73 | -89.29 | -77.77 | -55.49 | -20.71 | -6.87 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.3 | 3.6 | 5.7 | 1.1 | 2.3 | 4.1 | 5.2 | 1.9 | 4.0 | 4.4 | 7.5 | 15.6 | 15.6 | 17.5 | 7.6 | 8.6 | 8.6 | - | - | 7.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 104.8 | 231.4 | - | 26.1 | 9.5 | 14.6 | - | 91.2 | 2098.8 | 1779.4 | 63.9 | 5383.8 | 48.9 | - | 3506.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 104.8 | 231.4 | - | 26.1 | 9.5 | 14.6 | - | 91.2 | 2098.8 | 1779.4 | 63.9 | 5383.8 | 48.9 | - | 3506.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | 104.8 | 231.4 | - | 26.1 | 9.5 | 14.6 | - | 91.2 | 2098.8 | 1779.4 | 63.9 | 5383.8 | 48.9 | - | 3506.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency